Pharma-Germany-Regional Association Bavaria elects Susanne Lamminger as new chairwoman
10.07.2025 17:56
The Bavarian regional association of Pharma Deutschland elected a new chairwoman at its general meeting on July 10 in Pullach near Munich. Susanne Lamminger, member of the board of directors of Hexal AG and Head of Corporate Affairs at Sandoz in Holzkirchen, will succeed Dr. Günter Auerbach.
The new chairwoman praises the regional association's work to date and looks forward to her new challenge: "I am very pleased to be able to continue my work in the regional association in my new role. The regional association was founded almost exactly a year ago, and since then, together with our member companies, we have created a solid foundation to further strengthen Bavaria as a pharmaceutical location. We will continue the constructive dialogue with politicians in established and new formats and continue to network within the healthcare industry. We will be represented at the upcoming Bavarian Pharma Summit next week."
The regional association's board of directors will be expanded by Sascha Hanselmann (BU Head Central Cluster Pharma at Baxter) and Andreas Pollner (General Manager Germany at Moderna). Jörg Wieczorek, Chairman of the Board of Directors of Pharma Deutschland, and Dorothee Brakmann, CEO of the association, sincerely thank Dr. Auerbach for his commitment and congratulate Ms. Lamminger on her election. Pharma Deutschland will further expand its regional association work and will create four new positions starting in January 2026.